BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31497919)

  • 1. Inhibition of tropomyosine receptor kinase B on the migration of human Schwann cell and dispersion of oral tongue squamous cell carcinoma in vitro.
    Ein L; Bracho O; Mei C; Patel J; Boyle T; Monje P; Fernandez-Valle C; Bas E; Thomas G; Weed D; Sargi Z; Dinh C
    Head Neck; 2019 Dec; 41(12):4069-4075. PubMed ID: 31497919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of BDNF-TRKB Interactions on Schwann Cell-induced Oral Squamous Cell Carcinoma Dispersion
    Ein L; Mei C; Bracho O; Bas E; Monje P; Weed D; Sargi Z; Thomas G; Dinh C
    Anticancer Res; 2019 Nov; 39(11):5933-5942. PubMed ID: 31704818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schwann cells promote EMT and the Schwann-like differentiation of salivary adenoid cystic carcinoma cells via the BDNF/TrkB axis.
    Shan C; Wei J; Hou R; Wu B; Yang Z; Wang L; Lei D; Yang X
    Oncol Rep; 2016 Jan; 35(1):427-35. PubMed ID: 26530352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-derived neurotrophic factor/tropomyosin-related kinase B signaling pathway contributes to the aggressive behavior of lung squamous cell carcinoma.
    Ozono K; Ohishi Y; Onishi H; Nakamura K; Motoshita J; Kato M; Nakanishi R; Nakamura M; Oda Y
    Lab Invest; 2017 Nov; 97(11):1332-1342. PubMed ID: 28604655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral squamous cell carcinoma-released brain-derived neurotrophic factor contributes to oral cancer pain by peripheral tropomyosin receptor kinase B activation.
    Grayson M; Arris D; Wu P; Merlo J; Ibrahim T; Fang-Mei C; Valenzuela V; Ganatra S; Ruparel S
    Pain; 2022 Mar; 163(3):496-507. PubMed ID: 34321412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of BDNF/TrkB/Akt pathway is associated with aggressiveness and unfavorable survival in oral squamous cell carcinoma.
    Moraes JK; Wagner VP; Fonseca FP; Amaral-Silva GKD; de Farias CB; Pilar EFS; Gregianin L; Roesler R; Vargas PA; Martins MD
    Oral Dis; 2019 Nov; 25(8):1925-1936. PubMed ID: 31498938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BDNF activates TrkB/PLCγ1 signaling pathway to promote proliferation and invasion of ovarian cancer cells through inhibition of apoptosis.
    Xu Y; Jiang WG; Wang HC; Martin T; Zeng YX; Zhang J; Qi YS
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5093-5100. PubMed ID: 31298409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic Cancer.
    Oyama Y; Nagao S; Na L; Yanai K; Umebayashi M; Nakamura K; Nagai S; Fujimura A; Yamasaki A; Nakayama K; Morisaki T; Onishi H
    Anticancer Res; 2021 Aug; 41(8):4047-4052. PubMed ID: 34281873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of BDNF, TrkB, and p53 in early-stage squamous cell carcinoma of the uterine cervix.
    Moon A; Won KY; Lee JY; Kang I; Lee SK; Lee J
    Pathology; 2011 Aug; 43(5):453-8. PubMed ID: 21670725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer.
    Tanaka K; Okugawa Y; Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Araki T; Uchida K; Mohri Y; Kusunoki M
    PLoS One; 2014; 9(5):e96410. PubMed ID: 24801982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of choriocarcinoma invasion and metastasis following blockade of BDNF/TrkB signaling.
    Kawamura K; Kawamura N; Okamoto N; Manabe M
    Cancer Med; 2013 Dec; 2(6):849-61. PubMed ID: 24403258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K252a induces anoikis-sensitization with suppression of cellular migration in Epstein-Barr virus (EBV)--associated nasopharyngeal carcinoma cells.
    Ng YK; Wong EY; Lau CP; Chan JP; Wong SC; Chan AS; Kwan MP; Tsao SW; Tsang CM; Lai PB; Chan AT; Lui VW
    Invest New Drugs; 2012 Feb; 30(1):48-58. PubMed ID: 20694504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-derived neurotrophic factor (BDNF) -TrKB signaling modulates cancer-endothelial cells interaction and affects the outcomes of triple negative breast cancer.
    Tsai YF; Tseng LM; Hsu CY; Yang MH; Chiu JH; Shyr YM
    PLoS One; 2017; 12(6):e0178173. PubMed ID: 28604807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-Derived Neurotrophic Factor Regulates Ishikawa Cell Proliferation through the TrkB-ERK1/2 Signaling Pathway.
    Cao M; Niu Q; Xiang X; Yuan C; Iqbal T; Huang Y; Tian M; Zhao Z; Li C; Zhou X
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33302387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma.
    Kupferman ME; Jiffar T; El-Naggar A; Yilmaz T; Zhou G; Xie T; Feng L; Wang J; Holsinger FC; Yu D; Myers JN
    Oncogene; 2010 Apr; 29(14):2047-59. PubMed ID: 20101235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Secretome of Aged Fibroblasts Promotes EMT-Like Phenotype in Primary Keratinocytes from Elderly Donors through BDNF-TrkB Axis.
    Tinaburri L; Valente C; Teson M; Minafò YA; Cordisco S; Guerra L; Dellambra E
    J Invest Dermatol; 2021 Apr; 141(4S):1052-1062.e12. PubMed ID: 32931807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of the BDNF/TrKB pathway promotes epithelial-mesenchymal transition, as well as the migration and invasion of cervical cancer.
    Yuan Y; Ye HQ; Ren QC
    Int J Oncol; 2018 Feb; 52(2):461-472. PubMed ID: 29345295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-Derived Neurotrophin and TrkB in Head and Neck Squamous Cell Carcinoma.
    Dudás J; Riml A; Tuertscher R; Pritz C; Steinbichler TB; Schartinger VH; Sprung S; Glueckert R; Schrott-Fischer A; Johnson Chacko L; Riechelmann H
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30641914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases.
    Contreras-Zárate MJ; Day NL; Ormond DR; Borges VF; Tobet S; Gril B; Steeg PS; Cittelly DM
    Oncogene; 2019 Jun; 38(24):4685-4699. PubMed ID: 30796353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Potentials of BDNF/TrkB in Breast Cancer; Current Status and Perspectives.
    Tajbakhsh A; Mokhtari-Zaer A; Rezaee M; Afzaljavan F; Rivandi M; Hassanian SM; Ferns GA; Pasdar A; Avan A
    J Cell Biochem; 2017 Sep; 118(9):2502-2515. PubMed ID: 28230291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.